336 related articles for article (PubMed ID: 12939222)
1. Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis.
Köhler R; Wulff H; Eichler I; Kneifel M; Neumann D; Knorr A; Grgic I; Kämpfe D; Si H; Wibawa J; Real R; Borner K; Brakemeier S; Orzechowski HD; Reusch HP; Paul M; Chandy KG; Hoyer J
Circulation; 2003 Sep; 108(9):1119-25. PubMed ID: 12939222
[TBL] [Abstract][Full Text] [Related]
2. Selective blockade of the intermediate-conductance Ca2+-activated K+ channel suppresses proliferation of microvascular and macrovascular endothelial cells and angiogenesis in vivo.
Grgic I; Eichler I; Heinau P; Si H; Brakemeier S; Hoyer J; Köhler R
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):704-9. PubMed ID: 15662023
[TBL] [Abstract][Full Text] [Related]
3. The K+ channel iKCA1 potentiates Ca2+ influx and degranulation in human lung mast cells.
Mark Duffy S; Berger P; Cruse G; Yang W; Bolton SJ; Bradding P
J Allergy Clin Immunol; 2004 Jul; 114(1):66-72. PubMed ID: 15241346
[TBL] [Abstract][Full Text] [Related]
4. Mitogenic modulation of Ca2+ -activated K+ channels in proliferating A7r5 vascular smooth muscle cells.
Si H; Grgic I; Heyken WT; Maier T; Hoyer J; Reusch HP; Köhler R
Br J Pharmacol; 2006 Aug; 148(7):909-17. PubMed ID: 16770324
[TBL] [Abstract][Full Text] [Related]
5. [Intermediate-conductance-Ca2+-activated K+ channels are overexpressed in endometrial cancer and involved in regulating proliferation of endometrial cancer cells].
Wang ZH; Feng YJ; Su M; Yi XF
Zhonghua Fu Chan Ke Za Zhi; 2007 Feb; 42(2):111-5. PubMed ID: 17442186
[TBL] [Abstract][Full Text] [Related]
6. Effects of Ginkgo biloba extract on the proliferation of vascular smooth muscle cells in vitro and on intimal thickening and interleukin-1beta expression after balloon injury in cholesterol-fed rabbits in vivo.
Lin SJ; Yang TH; Chen YH; Chen JW; Kwok CF; Shiao MS; Chen YL
J Cell Biochem; 2002; 85(3):572-82. PubMed ID: 11967997
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II activates intermediate-conductance Ca2+ -activated K+ channels in arterial smooth muscle cells.
Hayabuchi Y; Nakaya Y; Yasui S; Mawatari K; Mori K; Suzuki M; Kagami S
J Mol Cell Cardiol; 2006 Dec; 41(6):972-9. PubMed ID: 16919291
[TBL] [Abstract][Full Text] [Related]
8. Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat.
Sollott SJ; Cheng L; Pauly RR; Jenkins GM; Monticone RE; Kuzuya M; Froehlich JP; Crow MT; Lakatta EG; Rowinsky EK
J Clin Invest; 1995 Apr; 95(4):1869-76. PubMed ID: 7706494
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of vascular smooth muscle cell proliferation and neointimal formation in injured arteries by a novel, oral mitogen-activated protein kinase/extracellular signal-regulated kinase inhibitor.
Gennaro G; Ménard C; Michaud SE; Deblois D; Rivard A
Circulation; 2004 Nov; 110(21):3367-71. PubMed ID: 15520324
[TBL] [Abstract][Full Text] [Related]
10. Functional ion channels and cell proliferation in 3T3-L1 preadipocytes.
Zhang XH; Zhang YY; Sun HY; Jin MW; Li GR
J Cell Physiol; 2012 May; 227(5):1972-9. PubMed ID: 21732368
[TBL] [Abstract][Full Text] [Related]
11. Xenogenic smooth muscle cell immunization reduces neointimal formation in balloon-injured rabbit carotid arteries.
Shinohara M; Kawashima S; Yamashita T; Takaya T; Toh R; Ishida T; Ueyama T; Inoue N; Hirata K; Yokoyama M
Cardiovasc Res; 2005 Nov; 68(2):249-58. PubMed ID: 16039635
[TBL] [Abstract][Full Text] [Related]
12. Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis.
Beeton C; Wulff H; Barbaria J; Clot-Faybesse O; Pennington M; Bernard D; Cahalan MD; Chandy KG; Béraud E
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13942-7. PubMed ID: 11717451
[TBL] [Abstract][Full Text] [Related]
13. Aldosterone-induced coronary dysfunction in transgenic mice involves the calcium-activated potassium (BKCa) channels of vascular smooth muscle cells.
Ambroisine ML; Favre J; Oliviero P; Rodriguez C; Gao J; Thuillez C; Samuel JL; Richard V; Delcayre C
Circulation; 2007 Nov; 116(21):2435-43. PubMed ID: 17984374
[TBL] [Abstract][Full Text] [Related]
14. Protective role of clusterin/apolipoprotein J against neointimal hyperplasia via antiproliferative effect on vascular smooth muscle cells and cytoprotective effect on endothelial cells.
Kim HJ; Yoo EK; Kim JY; Choi YK; Lee HJ; Kim JK; Jeoung NH; Lee KU; Park IS; Min BH; Park KG; Lee CH; Aronow BJ; Sata M; Lee IK
Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1558-64. PubMed ID: 19696405
[TBL] [Abstract][Full Text] [Related]
15. Blockage of intermediate-conductance Ca2+-activated K+ channels inhibit human pancreatic cancer cell growth in vitro.
Jäger H; Dreker T; Buck A; Giehl K; Gress T; Grissmer S
Mol Pharmacol; 2004 Mar; 65(3):630-8. PubMed ID: 14978241
[TBL] [Abstract][Full Text] [Related]
16. Dominant negative insulin-like growth factor-1 receptor inhibits neointimal formation through suppression of vascular smooth muscle cell migration and proliferation, and induction of apoptosis.
Lim HJ; Park HY; Ko YG; Lee SH; Cho SY; Lee EJ; Jameson JL; Jang Y
Biochem Biophys Res Commun; 2004 Dec; 325(3):1106-14. PubMed ID: 15541402
[TBL] [Abstract][Full Text] [Related]
17. Selective intermediate-/small-conductance calcium-activated potassium channel (KCNN4) blockers are potent and effective therapeutics in experimental brain oedema and traumatic brain injury caused by acute subdural haematoma.
Mauler F; Hinz V; Horváth E; Schuhmacher J; Hofmann HA; Wirtz S; Hahn MG; Urbahns K
Eur J Neurosci; 2004 Oct; 20(7):1761-8. PubMed ID: 15379997
[TBL] [Abstract][Full Text] [Related]
18. Intermediate-conductance Ca2+-activated K+ channel, KCa3.1, as a novel therapeutic target for benign prostatic hyperplasia.
Ohya S; Niwa S; Kojima Y; Sasaki S; Sakuragi M; Kohri K; Imaizumi Y
J Pharmacol Exp Ther; 2011 Aug; 338(2):528-36. PubMed ID: 21602424
[TBL] [Abstract][Full Text] [Related]
19. Low molecular weight fucoidan prevents intimal hyperplasia in rat injured thoracic aorta through the modulation of matrix metalloproteinase-2 expression.
Hlawaty H; Suffee N; Sutton A; Oudar O; Haddad O; Ollivier V; Laguillier-Morizot C; Gattegno L; Letourneur D; Charnaux N
Biochem Pharmacol; 2011 Jan; 81(2):233-43. PubMed ID: 20887714
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of intermediate-conductance Ca2+-activated K+ channel (IKCa1) mediates phenotypic modulation of coronary smooth muscle.
Tharp DL; Wamhoff BR; Turk JR; Bowles DK
Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2493-503. PubMed ID: 16798818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
